Performance of urine podocalyxin and microalbuminuria in the diagnosis of diabetic nephropathy
1. Department of Clinical Laboratory,the Forth Hospital in Wuhan,Hubei Wuhan 430030,China;2. Department of Clinical Laboratory,the First Hospital in Wuhan,Hubei Wuhan 430022,China;3. Central Laboratory,the Hospital of Integrated Traditional and Western Medicine in Wuhan,Hubei Wuhan 430022,China
YE Jun;LUO Hong;LI Kun;MA Wei . Performance of urine podocalyxin and microalbuminuria in the diagnosis of diabetic nephropathy[J]. , 2012, 27(7): 568-570.
[1]Fioretto P,Bruseghin M,Berto I,et al. Renal protection in diabetes:role of glycemic control[J]. J Am Soc Nephrol,2006,17(4 Suppl 2):S86-S89.[2]周 虹,金文平,马 威.GGT及AFP对原发性肝癌的ROC评价[J]. 中西医结合肝病杂志,2008,18(5):304-305.[3]Kanwar YS,Wada J,Sun L,et al. Diabetic nephropathy:mechanisms of renal disease progression[J]. Exp Biol Med(May wood),2008,233(1):4-11.[4]Doi T,Mima A,Matsubara T,et al. The current clinical problems for early phase of diabetic nephropathy and approach for pathogenesis of diabetic nephropathy[J]. Diabetes Res Clin Pract,2008,82(Suppl 1):S21-S24.[5]李金花,原爱红.糖尿病肾病足细胞损伤研究进展[J].中国中西医结合肾病杂志,2010,11(9):835-837.[6]Miyauchi M,Toyoda M,Kobayashi K,et al. Hypertrophy and loss of podocytes in diabetic nephropathy[J]. Intern Med,2009,48(18):1615-1620.